Navigation

Bipolar disorder (children) - aripiprazole [ID305]

Aripiprazole for the treatment and prevention of acute manic and mixed episodes in bipolar disorder in children and adolescents

Status: History
Expected date of issue: July 2013
Referral date: January 2010
Process: STA
Topic area:
 

NICE project team

Executive Lead: TBC
Technical Lead: Bernice Dillon
Communications manager: Alice Law
Project manager: Bijal Joshi
Top


 

Provisional schedule

Closing date for invited submissions / evidence submission: 15 June 2012
1st appraisal committee meeting: 09 April 2013
Top


 

Consultees and commentators

To be confirmed

Top


 

Project history

Date Update
24 July 2013 Guidance publishes
15 June Following on from advice received from the manufacturer, this appraisal has been rescheduled to align with latest regulatory expectations. The first Committee discussion will now take place on 9 April 2013. The second Committee discussion will take place on 6 June 2013
27 January 2012 Following on from advice received from the manufacturer, this appraisal has been rescheduled to align with latest regulatory expectations.  Therefore, we now anticipate that the appraisal will begin during mid-April 2012 when we will write to you about how you can get involved. The deadline for submissions is expected in approximately mid-June 2012.
12 August 2011 As you are aware, the Department of Health has asked us to  carry out a single technology appraisal of aripiprazole for the treatment and prevention of acute manic and mixed episodes in bipolar disorder in children and adolescents.

Please note that following on from advice received from the manufacturer, we now anticipate that the appraisal will begin during early March 2012 when we will write to you about how you can get involved. The deadline for submissions is expected in approximately early May 2012.
Top


 

Key documents

This page was last updated: 30 July 2013

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.